Author Question: If the Kyoto Protocol requires developed countries to reduce emissions of greenhouse gases, but ... (Read 137 times)

tth

  • Hero Member
  • *****
  • Posts: 579
If the Kyoto Protocol requires developed countries to reduce emissions of greenhouse gases, but developing countries are not required to do so, why might a developed country still agree? Should it?
 
  What will be an ideal response?

Question 2

Which of the following is an argument in favor of the liberalization?
 
  (a) Increased technical efficiency.
  (b) Accelerated technical progress.
  (c) Decreased shortages of foreign exchange.
  (d) All of the above.
  (e) both (a) and (b) are correct.



Shshxj

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

This is meant to be a speculative question, but allows students to discuss externalities, free riders, and the issue of cost/benefit analysis. The student can still answer yes or no to the final question.

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library